NeuroBo Pharmaceuticals (NRBO) Competitors $1.54 -0.04 (-2.22%) As of 04/2/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRBO vs. TCBS, CLST, CFSB, OPHC, DGHI, SDIG, MSVB, CIZN, USIO, and OMCCShould you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include Texas Community Bancshares (TCBS), Catalyst Bancorp (CLST), CFSB Bancorp (CFSB), OptimumBank (OPHC), Digihost Technology (DGHI), Stronghold Digital Mining (SDIG), Mid-Southern Bancorp (MSVB), Citizens (CIZN), Usio (USIO), and Old Market Capital (OMCC). These companies are all part of the "banking" industry. NeuroBo Pharmaceuticals vs. Texas Community Bancshares Catalyst Bancorp CFSB Bancorp OptimumBank Digihost Technology Stronghold Digital Mining Mid-Southern Bancorp Citizens Usio Old Market Capital Texas Community Bancshares (NASDAQ:TCBS) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability. Which has more risk and volatility, TCBS or NRBO? Texas Community Bancshares has a beta of -0.01, indicating that its share price is 101% less volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its share price is 126% less volatile than the S&P 500. Is TCBS or NRBO more profitable? NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Texas Community Bancshares' net margin of -10.81%. Texas Community Bancshares' return on equity of -4.11% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Texas Community Bancshares-10.81% -4.11% -0.48% NeuroBo Pharmaceuticals N/A -189.12%-122.31% Does the media favor TCBS or NRBO? In the previous week, Texas Community Bancshares had 3 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 3 mentions for Texas Community Bancshares and 0 mentions for NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals' average media sentiment score of 0.00 beat Texas Community Bancshares' score of -0.09 indicating that NeuroBo Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Texas Community Bancshares Neutral NeuroBo Pharmaceuticals Neutral Does the MarketBeat Community favor TCBS or NRBO? NeuroBo Pharmaceuticals received 27 more outperform votes than Texas Community Bancshares when rated by MarketBeat users. Likewise, 75.00% of users gave NeuroBo Pharmaceuticals an outperform vote while only 0.00% of users gave Texas Community Bancshares an outperform vote. CompanyUnderperformOutperformTexas Community BancsharesOutperform VotesNo VotesUnderperform Votes1100.00% NeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% Do institutionals & insiders have more ownership in TCBS or NRBO? 15.8% of Texas Community Bancshares shares are held by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. 19.1% of Texas Community Bancshares shares are held by company insiders. Comparatively, 1.1% of NeuroBo Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend TCBS or NRBO? NeuroBo Pharmaceuticals has a consensus target price of $10.00, indicating a potential upside of 549.35%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NeuroBo Pharmaceuticals is more favorable than Texas Community Bancshares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Texas Community Bancshares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, TCBS or NRBO? Texas Community Bancshares has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTexas Community Bancshares$10.40M4.77-$730K-$0.44-36.22NeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A SummaryTexas Community Bancshares beats NeuroBo Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Remove Ads Get NeuroBo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRBO vs. The Competition Export to ExcelMetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.27M$6.72B$5.53B$7.50BDividend YieldN/A2.85%4.87%4.05%P/E RatioN/A6.9923.1218.08Price / SalesN/A198.60360.0289.38Price / CashN/A65.6738.1634.64Price / Book1.035.926.473.99Net Income-$12.47M$142.37M$3.21B$247.18M7 Day Performance-1.28%-7.24%-4.97%-4.25%1 Month Performance5.48%-10.45%-0.14%-6.87%1 Year Performance-60.41%-14.58%6.19%-3.73% NeuroBo Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRBONeuroBo Pharmaceuticals1.2168 of 5 stars$1.54-2.2%$10.00+549.4%-60.4%$13.27MN/A0.0010Gap UpTCBSTexas Community Bancshares0.8377 of 5 stars$16.33-0.8%N/A+8.8%$50.87M$10.40M-22.9960Gap DownCLSTCatalyst Bancorp0.6528 of 5 stars$11.66flatN/A-3.7%$50.63M$5.56M-15.7660Positive NewsCFSBCFSB BancorpN/A$7.71-3.1%N/A+5.6%$50.49M$7.28M-771.0030Gap DownOPHCOptimumBank2.8885 of 5 stars$4.27-3.0%$5.25+23.0%-5.1%$50.18M$39.31M3.2340DGHIDigihost Technology1.7037 of 5 stars$1.37+11.0%$2.50+83.2%-10.8%$49.56M$42.15M-2.5310SDIGStronghold Digital Mining2.7406 of 5 stars$2.81flat$6.17+119.5%-24.5%$48.45M$79.53M-0.7620MSVBMid-Southern BancorpN/A$15.90flatN/A+10.0%$45.94M$8.88M39.7440CIZNCitizensN/A$8.04-3.6%N/A+2.8%$45.32M$40.95M8.20250Analyst ForecastHigh Trading VolumeUSIOUsio3.4546 of 5 stars$1.59+5.3%$5.00+214.5%-9.5%$43.14M$81.03M17.67110Gap UpOMCCOld Market CapitalN/A$6.40flatN/AN/A$42.88M$4.59M-8.107Gap Down Remove Ads Related Companies and Tools Related Companies Texas Community Bancshares Alternatives Catalyst Bancorp Alternatives CFSB Bancorp Alternatives OptimumBank Alternatives Digihost Technology Alternatives Stronghold Digital Mining Alternatives Mid-Southern Bancorp Alternatives Citizens Alternatives Usio Alternatives Old Market Capital Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRBO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRBO Stock Free NRBO Stock Alerts